 |
domperidone |
|---|---|
| Trade Name | |
| Orphan Indication | Hypoprolactinemia in breastfeeding mothers, and in some hypoprolactinemic conditions following the use of cabergoline or bromocriptine in mothers who wish to initiate or return to breastfeeding |
| USA Market Approval | USA |
| USA Designation Date | 2011-09-02 00:00:00 |
| Sponsor | Thomas W. Hale, RPh, PhD;Texas Tech University Health Sciences Ctr., 1400 Coulter Suite 1400;Amarillo, Texas, 79106 |
